Robert Holloway
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Neurology |
|---|
| Address | University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 673
Rochester NY 14642
|
|---|
|
|
|
| Title | Acting Chairman |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Neurology |
|---|
|
|
|---|
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Community and Preventive Medicine |
|---|
|
|
|---|
|
| 1984 |
|
| University Scholar | University of Connecticut | | 1985 |
|
| Phi Beta Kappa | University of Connecticut | | 1985 |
|
| Olin Award for Excellence in Undergraduate Research in Cellular and Molecular Biology | University of Connecticut | | 1998 |
|
| ISTAHC Award for 1997 for finest article published in 1997
" Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE. The cost-effectiveness of magnetic resonance imaging in patients with equivocal neurological symptoms. Int J Technol Assess Health Care, 1997:13:21-34. | | 1998 |
|
| Quality Achievement Award for Physician Leadership in Performance Improvement | University of Rochester | | 2002 |
-
| 2003 | Harry L. Segal Prize for Excellence in Third Year Teaching | University of Rochester School of Medicine and Dentistry | | 2002 |
-
| 2003 | Neurology Faculty Teaching Award | University of Rochester School of Medicine and Dentistry | | 2004 |
|
| Teacher Recognition Award | American Academy of Neurology | | 2005 |
|
| Medical Center Board Excellence Award | Palliative Care Team | | 2006 |
|
| Neurology Senior Faculty Teaching Award | University of Rochester School of Medicine and Dentistry | | 2006 |
|
| Leadership Development for Physicians in Academic Health Centers | The Department of Health Policy and Management | | 2006 |
|
| Nominee | AAMC Humanism in Medicine Award | | 2006 |
|
| Co-Chair | Stroke & Stroke Rehabilitation Work Group-Physician Consortium f | | 2007 |
-
| 2012 | Best Doctors in America | Best Doctors, Inc. | | 2008 |
|
| Junior Faculty Mentoring Award | University of Rochester Medical Center | | 2011 |
|
| Alpha Omega Alpha Faculty Inductee | University of Rochester |
Dr. Holloway's major research interests are technology assessment and cost-effectiveness of neurological practices and policies, methods to improve the quality and safety of medical care, and conflicts of interest in research and practice.
-
Holloway RG, Gramling R, Kelly AG. Estimating and communicating prognosis in advanced neurologic disease. Neurology. 2013 Feb 19; 80(8):764-72.
-
Benesch CG, Holloway RG. Too important to fail. Ann Neurol. 2013 Feb; 73(2):153-4.
-
Kim SY, de Vries R, Wilson R, Parnami S, Frank S, Kieburtz K, Holloway RG. Research participants' "irrational" expectations: common or commonly mismeasured? IRB. 2013 Jan-Feb; 35(1):1-9.
-
Manchak M, Holloway R. Adding clopidogrel to aspirin did not reduce recurrent stroke and increased bleeding in lacunar stroke. Ann Intern Med. 2012 Dec 18; 157(12):JC6-2.
-
Creutzfeldt CJ, Holloway RG. Treatment decisions after severe stroke: uncertainty and biases. Stroke. 2012 Dec; 43(12):3405-8.
-
Kaye SB, Fehrenbacher L, Holloway R, Amit A, Karlan B, Slomovitz B, Sabbatini P, Fu L, Yauch RL, Chang I, Reddy JC. A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission. Clin Cancer Res. 2012 Dec 1; 18(23):6509-18.
-
Weaver FM, Stroupe KT, Cao L, Holloway RG, Vickrey BG, Simuni T, Hendricks A, Ippolito D. Parkinson's disease medication use and costs following deep brain stimulation. Mov Disord. 2012 Sep 15; 27(11):1398-403.
-
Kelly AG, Hoskins KD, Holloway RG. Early stroke mortality, patient preferences, and the withdrawal of care bias. Neurology. 2012 Aug 28; 79(9):941-4.
-
Kim SY, De Vries R, Holloway RG, Wilson R, Parnami S, Kim HM, Frank S, Kieburtz K. Sham surgery controls in Parkinson's disease clinical trials: Views of participants. Mov Disord. 2012 Sep 15; 27(11):1461-5.
-
Quill TE, Holloway RG. Evidence, preferences, recommendations--finding the right balance in patient care. N Engl J Med. 2012 May 3; 366(18):1653-5.
-
Xian Y, Holloway RG, Pan W, Peterson ED. Challenges in assessing hospital-level stroke mortality as a quality measure: comparison of ischemic, intracerebral hemorrhage, and total stroke mortality rates. Stroke. 2012 Jun; 43(6):1687-90.
-
Gutmann L, Holloway RG. Reflections for october. Neurology. 2012 Mar 6; 78(10):765-6.
-
Kim SY, Wilson RM, Kim HM, Holloway RG, De Vries RG, Frank SA, Kieburtz K. Comparison of enrollees and decliners of Parkinson disease sham surgery trials. Mov Disord. 2012 Apr; 27(4):506-11.
-
Creutzfeldt CJ, Holloway RG, Walker M. Symptomatic and palliative care for stroke survivors. J Gen Intern Med. 2012 Jul; 27(7):853-60.
-
Holloway RG. In lieu of flowers…. J Palliat Med. 2011 Dec; 14(12):1348-9.
-
Heatwole C, Johnson N, Holloway R, Noyes K. Plasma Exchange versus Intravenous Immunoglobulin for Myasthenia Gravis Crisis: An Acute Hospital Cost Comparison Study. J Clin Neuromuscul Dis. 2011 Dec; 13(2):85-94.
-
Ramirez PT, Adams S, Boggess JF, Burke WM, Frumovitz MM, Gardner GJ, Havrilesky LJ, Holloway R, Lowe MP, Magrina JF, Moore DH, Soliman PT, Yap S. Robotic-assisted surgery in gynecologic oncology: A Society of Gynecologic Oncology consensus statement Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol. 2012 Feb; 124(2):180-4.
-
Quill TE, Holloway R. Time-limited trials near the end of life. JAMA. 2011 Oct 5; 306(13):1483-4.
-
Noyes K, Bajorska A, Chappel A, Schwid SR, Mehta LR, Weinstock-Guttman B, Holloway RG, Dick AW. Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology. 2011 Jul 26; 77(4):355-63.
-
Holloway RG, Ringel SP. Getting to value in neurological care: a roadmap for academic neurology. Ann Neurol. 2011 Jun; 69(6):909-18.
-
Olden AM, Holloway R, Ladwig S, Quill TE, van Wijngaarden E. Palliative care needs and symptom patterns of hospitalized elders referred for consultation. J Pain Symptom Manage. 2011 Sep; 42(3):410-8.
-
Hyland MH, Holloway RG. Pearls & Oy-sters: a stroke of luck: detecting type A aortic dissection by MRA. Neurology. 2011 Feb 22; 76(8):e31-3.
-
Xian Y, Holloway RG, Noyes K, Shah MN, Friedman B. Racial differences in mortality among patients with acute ischemic stroke: an observational study. Ann Intern Med. 2011 Feb 1; 154(3):152-9.
-
Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, Chappel AR, Peterson ED, Friedman B. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA. 2011 Jan 26; 305(4):373-80.
-
Singh R, Nind G, Tucker G, Nguyen N, Holloway R, Bate J, Shetti M, George B, Tam W. Narrow-band imaging in the evaluation of villous morphology: a feasibility study assessing a simplified classification and observer agreement. Endoscopy. 2010 Nov; 42(11):889-94.
-
Young KC, Holloway RG, Burgin WS, Benesch CG. A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy. J Stroke Cerebrovasc Dis. 2010 Sep-Oct; 19(5):404-9.
-
Kelly AG, Holloway RG. Health state preferences and decision-making after malignant middle cerebral artery infarctions. Neurology. 2010 Aug 24; 75(8):682-7.
-
Kim SY, Holloway RG. Is it research?: an increasingly common question. Neurology. 2010 Jul 13; 75(2):102-4.
-
Holloway RG, Quill TE. Treatment decisions after brain injury--tensions among quality, preference, and cost. N Engl J Med. 2010 May 13; 362(19):1757-9.
-
Holloway RG, Ladwig S, Robb J, Kelly A, Nielsen E, Quill TE. Palliative care consultations in hospitalized stroke patients. J Palliat Med. 2010 Apr; 13(4):407-12.
-
Xian Y, Pan W, Peterson ED, Heidenreich PA, Cannon CP, Hernandez AF, Friedman B, Holloway RG, Fonarow GC. Are quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals. Am Heart J. 2010 Feb; 159(2):207-14.
-
Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med. 2010 Jan; 13(1):59-65.
-
Pogoda TK, Cramer IE, Meterko M, Lin H, Hendricks A, Holloway RG, Charns MP. Patient and organizational factors related to education and support use by Veterans with Parkinson's disease. Mov Disord. 2009 Oct 15; 24(13):1916-24.
-
Dorsey ER, Thompson JP, Carrasco M, de Roulet J, Vitticore P, Nicholson S, Johnston SC, Holloway RG, Moses H. Financing of U.S. biomedical research and new drug approvals across therapeutic areas. PLoS One. 2009; 4(9):e7015.
-
Friedman D, Feldon S, Holloway R, Fisher S. Utilization, diagnosis, treatment and cost of migraine treatment in the emergency department. Headache. 2009 Sep; 49(8):1163-73.
-
Yurcheshen ME, Guttuso T, McDermott M, Holloway RG, Perlis M. Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model. J Womens Health (Larchmt). 2009 Sep; 18(9):1355-60.
-
Kim SY, Schrock L, Wilson RM, Frank SA, Holloway RG, Kieburtz K, de Vries RG. An approach to evaluating the therapeutic misconception. IRB. 2009 Sep-Oct; 31(5):7-14.
-
Dorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RG. Selegiline shortage: Causes and costs of a generic drug shortage. Neurology. 2009 Jul 21; 73(3):213-7.
-
Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009 Jul; 40(7):2616-34.
-
Dorsey ER, Thompson JP, Frasier M, Sherer T, Fiske B, Nicholson S, Johnston SC, Holloway RG, Moses H. Funding of Parkinson research from industry and US federal and foundation sources. Mov Disord. 2009 Apr 15; 24(5):731-7.
-
Holloway RG, Benesch C. When disclosures are more interesting than the evidence. Stroke. 2009 Feb; 40(2):e44; author reply e45.
-
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70.
-
Kelly A, Thompson JP, Tuttle D, Benesch C, Holloway RG. Public reporting of quality data for stroke: is it measuring quality? Stroke. 2008 Dec; 39(12):3367-71.
-
Thompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG. Quantitative risk-benefit analysis of natalizumab. Neurology. 2008 Jul 29; 71(5):357-64.
-
Kim SY, Holloway RG, Frank S, Wilson R, Kieburtz K. Trust in early phase research: therapeutic optimism and protective pessimism. Med Health Care Philos. 2008 Dec; 11(4):393-401.
-
Holloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO. Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines. Neurology. 2008 Jul 1; 71(1):57-63.
-
Bever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC. Invited article: Neurology and quality improvement: an introduction. Neurology. 2008 Apr 29; 70(18):1636-40.
-
O'Connor AB, Noyes K, Holloway RG. A cost-utility comparison of four first-line medications in painful diabetic neuropathy. Pharmacoeconomics. 2008; 26(12):1045-64.
-
Frank SA, Wilson R, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim SY. Ethics of sham surgery: perspective of patients. Mov Disord. 2008 Jan; 23(1):63-8.
-
Dorsey ER, Holloway RG. Quality of life in epilepsy, multiple sclerosis, and beyond. Ann Neurol. 2007 Oct; 62(4):307-8.
-
Holloway RG, Quill TE. Mortality as a measure of quality: implications for palliative and end-of-life care. JAMA. 2007 Aug 15; 298(7):802-4.
-
O'Connor AB, Noyes K, Holloway RG. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. J Am Geriatr Soc. 2007 Aug; 55(8):1176-84.
-
Biglan KM, Holloway RG, McDermott MP, Richard IH. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007 Jul 10; 69(2):187-95.
-
Norton SA, Hogan LA, Holloway RG, Temkin-Greener H, Buckley MJ, Quill TE. Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients. Crit Care Med. 2007 Jun; 35(6):1530-5.
-
Noyes K, Dick AW, Holloway RG. The implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation. Med Decis Making. 2007 May-Jun; 27(3):327-34.
-
Dorsey ER, Thompson JP, Noyes K, Dick AW, Holloway RG, Schwid SR. Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis. Neurology. 2007 May 1; 68(18):1524-8.
-
Langfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S. Health care costs decline after successful epilepsy surgery. Neurology. 2007 Apr 17; 68(16):1290-8.
-
Noyes K, Liu H, Holloway R, Dick AW. Accuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey. Mov Disord. 2007 Mar 15; 22(4):509-14.
-
Rizzo M, Glick TH. Medical errors after stroke: preventable or inevitable? Neurology. 2007 Feb 20; 68(8):542-3.
-
Holloway RG, Tuttle D, Baird T, Skelton WK. The safety of hospital stroke care. Neurology. 2007 Feb 20; 68(8):550-5.
-
Little DM, Holloway RG. Diffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture? Neurology. 2007 Jan 2; 68(1):9-10.
-
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1):41-7.
-
Dorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H. Financial anatomy of neuroscience research. Ann Neurol. 2006 Dec; 60(6):652-9.
-
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007 Jan 30; 68(5):384-6.
-
Kelly AG, Holloway RG. Review: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients. ACP J Club. 2006 Nov-Dec; 145(3):77.
-
Johnston KC, Holloway RG. There is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies. Neurology. 2006 Sep 12; 67(5):740-1.
-
Dorsey ER, Holloway RG, Ravina BM. Biomarkers in Parkinson's disease. Expert Rev Neurother. 2006 Jun; 6(6):823-31.
-
Henry JC, Holloway R. Review: lorazepam provides the best control for status epilepticus. Evid Based Med. 2006 Apr; 11(2):54.
-
Noyes K, Liu H, Holloway RG. What is the risk of developing parkinsonism following neuroleptic use? Neurology. 2006 Mar 28; 66(6):941-3.
-
Holloway RG, Józefowicz RF. Update in neurology. Ann Intern Med. 2006 Mar 21; 144(6):421-6.
-
Kim SY, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K. Volunteering for early phase gene transfer research in Parkinson disease. Neurology. 2006 Apr 11; 66(7):1010-5.
-
Henry JC, Holloway R. Review: Lorazepam provides the best control for status epilepticus. ACP J Club. 2006 Mar-Apr; 144(2):35.
-
Noyes K, Liu H, Li Y, Holloway R, Dick AW. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov Disord. 2006 Mar; 21(3):362-72.
-
Noyes K, Dick AW, Holloway RG. Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life. Value Health. 2006 Jan-Feb; 9(1):28-38.
-
Holloway R. The Babinski sign: thumbs up or toes down? Neurology. 2005 Oct 25; 65(8):1147.
-
Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J. Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005 Sep 27; 65(6):794-801.
-
Holloway R. Protein-energy supplementation of normal hospital diet did not improve outcomes after recent stroke. ACP J Club. 2005 Sep-Oct; 143(2):36.
-
Holloway R. Timing and route of enteral tube-feeding did not reduce death or poor outcome in stroke and dysphagia. ACP J Club. 2005 Sep-Oct; 143(2):37.
-
Kim SY, Frank S, Holloway R, Zimmerman C, Wilson R, Kieburtz K. Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers. Arch Neurol. 2005 Sep; 62(9):1357-60.
-
Holloway RG, Benesch CG, Burgin WS, Zentner JB. Prognosis and decision making in severe stroke. JAMA. 2005 Aug 10; 294(6):725-33.
-
Frank S, Kieburtz K, Holloway R, Kim SY. What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports. Neurology. 2005 Oct 11; 65(7):1101-3.
-
Williams LS, Holloway RG. How much is a good night's sleep worth? Stroke. 2005 Jun; 36(6):1293-4.
-
Guttuso T, Vitticore P, Holloway RG. Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report. J Neurosurg. 2005 Mar; 102(3):547-9.
-
Lindsay MP, Kapral MK, Gladstone D, Holloway R, Tu JV, Laupacis A, Grimshaw JM. The Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care. CMAJ. 2005 Feb 1; 172(3):363-5.
-
Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R. The role of radiotracer imaging in Parkinson disease. Neurology. 2005 Jan 25; 64(2):208-15.
-
Holloway RG. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2005 Jan 11; 64(1):172-4; author reply 172-4.
-
Noyes K, Dick AW, Holloway RG. Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness. Pharmacoeconomics. 2005; 23(12):1257-70.
-
Noyes K, Dick AW, Holloway RG. Pramipexole v. levodopa as initial treatment for Parkinson's disease: a randomized clinical-economic trial. Med Decis Making. 2004 Sep-Oct; 24(5):472-85.
-
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004 Sep; 19(9):1020-8.
-
Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis. Neurology. 2004 Aug 24; 63(4):718-20.
-
Holloway R, Nesbit K, Bordley D, Noyes K. Teaching and evaluating first and second year medical students' practice of evidence-based medicine. Med Educ. 2004 Aug; 38(8):868-78.
-
Tuttle D, Holloway R, Baird T, Sheehan B, Skelton WK. Electronic reporting to improve patient safety. Qual Saf Health Care. 2004 Aug; 13(4):281-6.
-
Noyes K, Holloway RG. Evidence from cost-effectiveness research. NeuroRx. 2004 Jul; 1(3):348-55.
-
Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53.
-
Holloway RG, Siderowf AD. Evidence-based neurotherapeutics: a spectrum of evidence. NeuroRx. 2004 Jul; 1(3):295-7.
-
Holloway R, Frank S. Review: anticholinergic drugs improve motor function and disability in Parkinson disease. ACP J Club. 2004 Jan-Feb; 140(1):15.
-
Holloway R, Dick AW. Editorial comment--stroke cost-effectiveness research: are acceptability curves acceptable? Stroke. 2004 Jan; 35(1):203-4.
-
Frank S, Holloway R. Medical errors on an inpatient neurology service. Neurology. 2003 Jul 22; 61(2):254-7.
-
Kim SY, Holloway RG. Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis. Am J Psychiatry. 2003 Jul; 160(7):1272-6.
-
Biglan KM, Holloway RG. Surrogate endpoints in Parkinson's disease research. Curr Neurol Neurosci Rep. 2003 Jul; 3(4):314-20.
-
Welsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J. Development and testing of the Parkinson's disease quality of life scale. Mov Disord. 2003 Jun; 18(6):637-45.
-
Nodera H, Herrmann DN, Holloway RG, Logigian EL. A Bayesian argument against rigid cut-offs in electrodiagnosis of median neuropathy at the wrist. Neurology. 2003 Feb 11; 60(3):458-64.
-
Gottlieb RH, La TC, Erturk EN, Sotack JL, Voci SL, Holloway RG, Syed L, Mikityansky I, Tirkes AT, Elmarzouky R, Zwemer FL, Joseph JV, Davis D, DiGrazio WJ, Messing EM. CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes. Radiology. 2002 Nov; 225(2):441-9.
-
Robling M, Matthews SJ, Hood K, Russell IT, Holloway R, Wilkinson C, Edwards AG, Austoker J, Cohen D, Mansel R, Pill RM, Stott NC, Thapar A. The development of a new site-specific measure of quality of life for breast problems: the Cardiff breast scales. Qual Life Res. 2002 Jun; 11(4):339-48.
-
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA. 2002 Apr 3; 287(13):1653-61.
-
Holloway RG, Dick AW. Clinical trial end points: on the road to nowhere? Neurology. 2002 Mar 12; 58(5):679-86.
-
Biglan KM, Holloway RG. A review of pramipexole and its clinical utility in Parkinson's disease. Expert Opin Pharmacother. 2002 Feb; 3(2):197-210.
-
Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis. Neurology. 2001 Nov 13; 57(9):1566-70.
-
Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R. Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology. 2001 Oct 23; 57(8):1434-40.
-
Holloway RG, Vickrey BG, Benesch C, Hinchey JA, Bieber J. Development of performance measures for acute ischemic stroke. Stroke. 2001 Sep; 32(9):2058-74.
-
Tomaszewski KJ, Holloway RG. Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis. Neurology. 2001 Aug 28; 57(4):663-71.
-
Biglan K, Holloway RG. Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials. Curr Neurol Neurosci Rep. 2001 Jul; 1(4):329-36.
-
Pippenger M, Holloway RG, Vickrey BG. Neurologists' use of ICD-9CM codes for dementia. Neurology. 2001 May 8; 56(9):1206-9.
-
Holloway RG, Panzer RJ. Lawyers, litigation, and liability: can they make patients safer? Neurology. 2001 Apr 24; 56(8):991-3.
-
A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group. Neurology. 2000 Nov 28; 55(10):1540-7.
-
Holloway RG, Ringel SP, Bernat JL, Keran CM, Lawyer BL. US neurologists: attitudes on rationing. Neurology. 2000 Nov 28; 55(10):1492-7.
-
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. JAMA. 2000 Oct 18; 284(15):1931-8.
-
Gifford DR, Holloway RG, Vickrey BG. Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia. Arch Intern Med. 2000 Oct 9; 160(18):2855-62.
-
Holloway RG, Benesch C, Rush SR. Stroke prevention: narrowing the evidence-practice gap. Neurology. 2000 May 23; 54(10):1899-906.
-
Siderowf AD, Holloway RG, Stern MB. Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions. Mov Disord. 2000 May; 15(3):439-45.
-
Zivin JA, Holloway RG. Weighing the evidence on DWI: caveat emptor. Neurology. 2000 Apr 25; 54(8):1552.
-
Larson WL, Holloway RG, Keran CM. Employment-seeking experiences of residents in 1996: a window into the neurology marketplace. Neurology. 2000 Jan 11; 54(1):214-8.
-
A randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group. Clin Neuropharmacol. 2000 Jan-Feb; 23(1):34-44.
-
Holloway RG, Kantrowitz JT, St James EC, Giang D, Schwarz K. Resolution of transient ischemic attacks and aortic arch thrombi on anticoagulant therapy. Eur Neurol. 2000; 43(3):184-5.
-
Holloway RG, Feasby TE. To test or not to test? That is the question. Neurology. 1999 Dec 10; 53(9):1905-7.
-
Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS. 1999 Sep 10; 13(13):1677-85.
-
Gifford DR, Holloway RG, Frankel MR, Albright CL, Meyerson R, Griggs RC, Vickrey BG. Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial. Ann Intern Med. 1999 Aug 17; 131(4):237-46.
-
Holloway RG, Gifford DR, Frankel MR, Vickrey BG. A randomized trial to implement practice recommendations: design and methods of the Dementia Care Study. Control Clin Trials. 1999 Aug; 20(4):369-85.
-
Holloway RG, Benesch CG, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke. 1999 Jul; 30(7):1340-9.
-
Holloway RG, Vickrey BG, Keran CM, Lesser E, Iverson D, Larson W, Swarztrauber K. US neurologists in the 1990's: trends in practice characteristics. Neurology. 1999 Apr 22; 52(7):1353-61.
-
Schifitto G, Holloway R. Cerebrovascular disease in patients with HIV-1 associated pulmonary hypertension. J NeuroAIDS. 1999; 2(2):57-64.
-
Uchino A, Numaguchi Y, Holloway RG, Cherian N. Reversible symptomatic venous congestion after treatment of dural arteriovenous fistula using NBCA. Radiat Med. 1998 Nov-Dec; 16(6):477-81.
-
Hoerger TJ, Bala MV, Rowland C, Greer M, Chrischilles EA, Holloway RG. Cost effectiveness of pramipexole in Parkinson's disease in the US. Pharmacoeconomics. 1998 Nov; 14(5):541-57.
-
Holloway RG, Courtright CE, Rahilly CR, Totterman SM, Shrier D. Magnetic resonance imaging in delayed brachial plexopathy following a clavicular fracture. Eur Neurol. 1998 Aug; 40(2):105-6.
-
Holloway RG, Ringel SP. Narrowing the evidence-practice gap. Strengthening the link between research and clinical practice. Neurology. 1998 Feb; 50(2):319-21.
-
Holloway RG, Witter DM, Mushlin AI, Lawton KB, McDermott MP, Samsa GP. Carotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995. Arch Neurol. 1998 Jan; 55(1):25-32.
-
Mushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE. The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care. 1997; 13(1):21-34.
-
Holloway RG. Cost-effectiveness analysis: what is it and how will it influence neurology. Ann Neurol. 1996 Jun; 39(6):818-23.
-
Holloway RG, Mushlin AI. Intracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy. Neurology. 1996 Apr; 46(4):1010-5.
-
Holloway RG, Witter DM, Lawton KB, Lipscomb J, Samsa G. Inpatient costs of specific cerebrovascular events at five academic medical centers. Neurology. 1996 Mar; 46(3):854-60.
-
Kieburtz K, Ketonen L, Cox C, Grossman H, Holloway R, Booth H, Hickey C, Feigin A, Caine ED. Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. Arch Neurol. 1996 Feb; 53(2):155-8.
-
Holloway RG, Kieburtz KD. Headache and the human immunodeficiency virus type 1 infection. Headache. 1995 May; 35(5):245-55.
-
Kiss I, Deák F, Holloway RG, Delius H, Mebust KA, Frimberger E, Argraves WS, Tsonis PA, Winterbottom N, Goetinck PF. Structure of the gene for cartilage matrix protein, a modular protein of the extracellular matrix. Exon/intron organization, unusual splice sites, and relation to alpha chains of beta 2 integrins, von Willebrand factor, complement factors B and C2, and epidermal growth factor. J Biol Chem. 1989 May 15; 264(14):8126-34.
|
Holloway's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
